- Home
- PEN
PEN
Penumbra Inc.
as 07-26-2024 4:00pm EST
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Upcoming Earnings Alert:
Get ready for potential market movements as Penumbra Inc. PEN prepares to release earnings report on 30 Jul 2024.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | ALAMEDA |
| Market Cap: | 7.0B | IPO Year: | 2015 |
| Target Price: | $265.36 | AVG Volume (30 days): | 352.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.37 | EPS Growth: | 1294.12 |
| 52 Week Low/High: | $170.59 - $310.51 | Next Earning Date: | 07-30-2024 |
| Revenue: | $1,095,779,000 | Revenue Growth: | 23.87% |
| Revenue Growth (this year): | 18.47% | Revenue Growth (next year): | 16.35% |
Stock Insider Trading Activity of Penumbra Inc. (PEN)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Jun 3 '24 | Sell | $187.64 | 252 | $47,285.28 | 63,236 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Jun 3 '24 | Sell | $188.52 | 137 | $25,827.24 | 63,099 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Jun 3 '24 | Sell | $189.78 | 24 | $4,554.72 | 63,075 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Jun 3 '24 | Sell | $190.51 | 141 | $26,861.91 | 62,934 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Jun 3 '24 | Sell | $191.51 | 46 | $8,809.46 | 62,888 | SEC Form 4 |
| Elsesser Adam | PEN | CEO and President | May 20 '24 | Sell | $200.62 | 7,719 | $1,548,585.78 | 949,863 | SEC Form 4 |
| Elsesser Adam | PEN | CEO and President | May 20 '24 | Sell | $201.16 | 6,319 | $1,271,130.04 | 943,544 | SEC Form 4 |
| Elsesser Adam | PEN | CEO and President | May 20 '24 | Sell | $202.46 | 679 | $137,470.34 | 942,865 | SEC Form 4 |
| Elsesser Adam | PEN | CEO and President | May 20 '24 | Sell | $203.35 | 283 | $57,548.05 | 942,582 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | May 13 '24 | Sell | $206.03 | 301 | $62,015.03 | 63,709 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | May 13 '24 | Sell | $206.65 | 48 | $9,919.20 | 63,661 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | May 13 '24 | Sell | $207.57 | 16 | $3,321.12 | 63,645 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | May 13 '24 | Sell | $209.29 | 32 | $6,697.28 | 63,613 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | May 13 '24 | Sell | $210.48 | 31 | $6,524.88 | 63,582 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | May 13 '24 | Sell | $211.96 | 36 | $7,630.56 | 63,546 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | May 13 '24 | Sell | $212.75 | 43 | $9,148.25 | 63,503 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | May 13 '24 | Sell | $214.43 | 15 | $3,216.45 | 63,488 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | May 13 '24 | Sell | $204.80 | 78 | $15,974.40 | 64,010 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Apr 1 '24 | Sell | $216.28 | 220 | $47,581.60 | 64,661 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Apr 1 '24 | Sell | $217.02 | 233 | $50,565.66 | 64,428 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Apr 1 '24 | Sell | $217.78 | 109 | $23,738.02 | 64,319 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Apr 1 '24 | Sell | $219.14 | 24 | $5,259.36 | 64,295 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Apr 1 '24 | Sell | $219.84 | 5 | $1,099.20 | 64,290 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Apr 1 '24 | Sell | $220.87 | 4 | $883.48 | 64,286 | SEC Form 4 |
| Roberts Johanna | PEN | EVP, Gen. Counsel & Secretary | Apr 1 '24 | Sell | $221.77 | 1 | $221.77 | 64,285 | SEC Form 4 |
Latest Penumbra Inc. News
PEN Breaking Stock News: Dive into PEN Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
PEN: Lowering target price to $169.00
Zacks
3 days ago
Penumbra (PEN) Earnings Expected to Grow: Should You Buy?
Zacks
9 days ago
Penumbra (PEN) Soars 3.3%: Is Further Upside Left in the Stock?
Zacks
9 days ago
Looking for a Growth Stock? 3 Reasons Why Penumbra (PEN) is a Solid Choice
Argus Research
10 days ago
PEN: Rating decreased to a SELL
Simply Wall St.
14 days ago
Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger
Argus Research
17 days ago
PEN: Raising target price to $187.00
GuruFocus.com
23 days ago
Insider Sale: EVP, General Counsel & Secretary Johanna Roberts Sells Shares of Penumbra Inc ...
Compare PEN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PEN Penumbra Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.